Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy

Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy

We present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intr...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Maria G. Kotoula, Fani Zacharaki, Evangelia E. Tsironi
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Karger Publishers 2012-06-01
Cyfres:	Case Reports in Ophthalmology
Pynciau:	Bevacizumab Central serous chorioretinopathy Photodynamic therapy
Mynediad Ar-lein:	http://www.karger.com/Article/FullText/339656

Eitemau Tebyg

Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
gan: Aditya Kelkar, et al.
Cyhoeddwyd: (2014-07-01)

Intravitreal bevacizumab for treatment of central serous chorioretinopathy
gan: Cihan Ünlü, et al.
Cyhoeddwyd: (2016-01-01)

Effect of Intravitreal Injection of Bevacizumab on Acute Central Serous Chorioretinopathy Patients who Visited Feiz Hospital during 2014–2015 Period
gan: Mohamad Reza Akhlaghi, et al.
Cyhoeddwyd: (2017-01-01)

Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
gan: Yu Wakatsuki, et al.
Cyhoeddwyd: (2021-01-01)

Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
gan: Jian-Bo Mao, et al.
Cyhoeddwyd: (2021-05-01)

Half-dose photodynamic therapy for chronic central serous chorioretinopathy
gan: Masood Naseripour, et al.
Cyhoeddwyd: (2016-01-01)

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
gan: Kyoko Fujita, et al.
Cyhoeddwyd: (2020-12-01)

Central Serous Chorioretinopathy: Pathogenesis and Management
gan: Semeraro F, et al.
Cyhoeddwyd: (2019-12-01)

Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
gan: Nao Aisu, MD, et al.
Cyhoeddwyd: (2022-06-01)

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
gan: Andrea Servillo, et al.
Cyhoeddwyd: (2023-06-01)

Management of chronic central serous chorioretinopathy
gan: Daren Hanumunthadu, et al.
Cyhoeddwyd: (2018-01-01)

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
gan: Ahmed S Al-Hinai, et al.
Cyhoeddwyd: (2011-01-01)

Massive Bilateral Serous Retinal Detachment in a Case of Hypertensive Chorioretinopathy
gan: Luis Villalba-Pinto, et al.
Cyhoeddwyd: (2014-07-01)

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy
gan: Seongyong Jeong, et al.
Cyhoeddwyd: (2024-10-01)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
gan: Hüseyin Baran Özdemir, et al.
Cyhoeddwyd: (2022-04-01)

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
gan: Miao Zeng, et al.
Cyhoeddwyd: (2022-03-01)

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
gan: Shimizu K, et al.
Cyhoeddwyd: (2017-08-01)

Clinical characteristics and risk factors of bacillary layer detachment in central serous chorioretinopathy: a comparative multicenter study
gan: Antonio M. Casella, et al.
Cyhoeddwyd: (2024-12-01)

Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
gan: Alp Atik, et al.
Cyhoeddwyd: (2017-08-01)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
gan: Asahi MG, et al.
Cyhoeddwyd: (2017-11-01)

Current Pharmacological Treatment Options for Central Serous Chorioretinopathy: A Review
gan: Massimo Nicolò, et al.
Cyhoeddwyd: (2020-09-01)

Oral eplerenone for the management of chronic central serous chorioretinopathy
gan: Rishi P Singh, et al.
Cyhoeddwyd: (2015-04-01)

Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy and Good Baseline Visual Acuity
gan: Aya Chubachi, et al.
Cyhoeddwyd: (2021-03-01)

Traumatic central serous chorioretinopathy
gan: Laura Steeples, et al.
Cyhoeddwyd: (2015-01-01)

Central Serous Chorioretinopathy Classification
gan: Manuel Vilela, et al.
Cyhoeddwyd: (2020-12-01)

The Effect of Metabolic Diseases on the Outcome of Bevacizumab Injection for Central Serous Retinopathy
gan: M Babaei, et al.
Cyhoeddwyd: (2022-03-01)

Central serous chorioretinopathy: Treatment
gan: Jong Beom Park, et al.
Cyhoeddwyd: (2022-01-01)

Intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
gan: Amr Abdel-Fattah Ali Gab-Alla
Cyhoeddwyd: (2015-01-01)

Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
gan: Özge Yanık, et al.
Cyhoeddwyd: (2022-04-01)

Short-term effects of photodynamic therapy on segmentation of retinal layers in central serous chorioretinopathy
gan: Shahram Agharokh, et al.
Cyhoeddwyd: (2021-01-01)

Central Serous Chorioretinopathy Associated with Tadalafil
gan: Abdulaziz Alsarhani, et al.
Cyhoeddwyd: (2022-11-01)

A randomized non-inferiority trial of 577nm subthreshold micropulse laser versus half-dose photodynamic therapy for acute central serous chorioretinopathy
gan: Lijun Zhou, et al.
Cyhoeddwyd: (2024-02-01)

Changes in the Foveal Outer Nuclear Layer of Central Serous Chorioretinopathy Patients Over the Disease Course and Their Response to Photodynamic Therapy
gan: Kaixin Deng, et al.
Cyhoeddwyd: (2022-01-01)

Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy
gan: David Rabinovitch, et al.
Cyhoeddwyd: (2024-12-01)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
gan: Mohabati D, et al.
Cyhoeddwyd: (2018-10-01)

Alternative management of central serous chorioretinopathy using intravitreal metoprolol
gan: Annelise Nicotti Gonçalves, et al.
Cyhoeddwyd: (2022-07-01)

Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
gan: Cuevas Pedro, et al.
Cyhoeddwyd: (2012-07-01)

Resolution of subretinal fluid in intractable central serous chorioretinopathy with high-dose intravitreal aflibercept
gan: Jonathan B. Lin, et al.
Cyhoeddwyd: (2025-03-01)

Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy
gan: K Sandeep, et al.
Cyhoeddwyd: (2023-01-01)

Delayed dark adaptation in central serous chorioretinopathy
gan: Archana Nigalye, et al.
Cyhoeddwyd: (2021-06-01)